Schrödinger, Inc. Profile Avatar - Palmy Investing

Schrödinger, Inc.

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The …
Medical - Healthcare Information Services
US, New York [HQ]
SDGR/Financial Reporting

Income Statements

7 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2017 2018 2019 2020 2021 2022 2023
Revenue
55.00 66.00 85.00 108.00 137.00 180.00 216.00
EPS
-0.43 -0.59 -0.41 -0.44 -1.43 -2.10 0.57
Profit
39.00 42.00 49.00 63.00 65.00 101.00 140.00
Pre Tax
-17.00 -28.00 -25.00 -26.00 -100.00 -149.00 42.00
ETR
-1.95 -0.27 1.12 -1.31 -0.41 -0.04 5.12
Net
-17.00 -28.00 -25.00 -26.00 -101.00 -149.00 40.00
EBITDA
-15.00 -24.00 -44.00 -85.00 -119.00 -144.00 -171.00
Operating Income
-19.00 -27.00 -38.00 -60.00 -111.00 -149.00 -177.00
Interest Income
- - - - 1.00 2.00 1.00 3.00 - -
Loss
-74.00 -94.00 -124.00 -169.00 -249.00 -327.00 -394.00
Cost of Revenue
-15.00 -23.00 -36.00 -44.00 -72.00 -79.00 -76.00
Operating Expenses
-58.00 -70.00 -87.00 -124.00 -177.00 -247.00 -317.00
Depreciation and Amortization
-1.00 -2.00 -3.00 -3.00 -2.00 -4.00 -5.00
Interest Expenses
- - - - - - - - - - - - - -
Other Expenses
-1.00 - - -12.00 -34.00 -10.00 - - -220.00
WA Shares Outstanding
40.00 48.00 63.00 60.00 70.00 71.00 71.00
End of SDGR's Analysis
CIK: 1490978 CUSIP: 80810D103 ISIN: US80810D1037 LEI: - UEI: -
Secondary Listings
SDGR has no secondary listings inside our databases.